Find activities

110 results

  • 1754 - Surgical Procedures for Gender Affirmation in Adults with Gender Incongruence - resubmission

    A further period of consultation is open on application 1754 – Surgical Procedures for Gender Affirmation in Adults with Gender Incongruence, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. Background MSAC application 1754 is progressing via a... More
    Opened 24 June 2026

  • MSAC Consultation Survey - Application 1819

    MSAC application 1819 Breyanzi (lisocabtagene maraleucel) for the treatment of large B-cell lymphoma. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 24 June 2026

  • MSAC Consultation Survey - Application 1803

    MSAC application 1803 - Implantation of an active middle ear implant (Vibroplasty) for treatment of mixed and conductive hearing loss. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Opened 24 June 2026

  • MSAC Consultation Survey - Application 1802

    MSAC application 1802 - Supervised oral food challenge (OFC) in patients with suspected food allergy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 24 June 2026

  • MSAC Consultation Survey - Application 1810

    MSAC application 1810 Genomic testing for the diagnosis of primary immunodeficiency (PID). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does... More
    Opened 24 June 2026

  • Feedback on consumer input

    We are seeking your views on how consumers and consumer organisations should receive feedback after they provide input on HTA committee agenda items. The Office of Health Technology Assessment’s (OHTA) Consumer Evidence and Engagement Unit (CEEU) is exploring practical ways to give clear and consistent feedback to consumers and consumer organisations about how their input was used during the health technology assessment (HTA) process and in HTA committee... More
    Opened 16 June 2026

  • EOI for feedback on consumer input

    The Office of Health Technology Assessment’s (OHTA) Consumer Evidence and Engagement Unit (CEEU) is exploring practical ways to provide consumers and consumer organisations with clear and consistent feedback about how their input is used in health technology assessment (HTA) processes and in HTA committee discussions. As part of this work, we are conducting an online survey and having virtual conversations with consumer organisations that will focus on: ... More
    Opened 15 June 2026

  • MSAC Consultation Survey - Application 1659.1

    MSAC application 1659.1 Catheter-based renal denervation for uncontrolled elevated systolic blood pressure. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1782.1

    MSAC application 1782.1 Genetic testing to detect estrogen receptor 1 (ESR1) variants in patients with estrogen receptor (ER)-positive, HER2-negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised elacestrant. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). ... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1795

    MSAC application 1795 Positron emission tomography / computed tomography (PET/CT) dopaminergic imaging for evaluating Parkinsonism. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1793

    MSAC application 1793 Diagnostic genomic testing for fetal anomalies Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1786 - resubmission

    A further period of consultation is open on application 1786 – FreeStyle Libre 2 continuous glucose monitoring (CGM) System for people with insulin-dependent type 2 diabetes, gestational diabetes and type 3c diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. ... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1812

    MSAC application 1812 Transcatheter Edge-To-Edge Repair (TEER) for the treatment of severe tricuspid regurgitation (TR) using the TriClip device. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1818

    MSAC Application 1818 – Expansion of specialist supervision criteria for MBS and PBS items for integrated, closed-system, extracorporeal photopheresis and methoxsalen (UVADEX®) for the treatment of Cutaneous T-Cell Lymphoma and chronic Graft Versus Host Disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). ... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1785 - resubmission

    A further period of consultation is open on application 1785 – Dexcom ONE+ Continuous Glucose Monitoring (CGM) System for people with insulin-dependent type 2 diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. MSAC previously considered application... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1823

    MSAC application 1823 177 Lutetium PSMA-617 for prostate specific membrane antigen (PSMA)-positive, taxane-naïve patients with metastatic castrate resistant prostate cancer (mCRPC). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a... More
    Opened 29 May 2026

  • MSAC Consultation Survey - Application 1822

    MSAC application 1822 F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for evaluation of complex infection. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian... More
    Opened 29 May 2026

  • MSAC Consultation Survey - Application 1825

    MSAC application 1825 Transcranial Doppler bubble test for patent foramen ovale. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by... More
    Opened 29 May 2026

  • MSAC Consultation Survey - Application 1821

    MSAC application 1821 Testing for Chromogranin A in patients with neuroendocrine neoplasms. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It... More
    Opened 29 May 2026

  • MSAC Consultation Survey - Application 1826

    MSAC application 1826 N-Terminal-pro Brain Natriuretic Peptide (NT-proBNP) testing to support management of patients with heart failure. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Opened 29 May 2026

  • MSAC Consultation Survey - Application 1820

    MSAC application 1820 In situ hybridisation (ISH) testing of tumour tissue to detect viral genomes (EBV and HPV). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health... More
    Opened 29 May 2026

  • MSAC Consultation Survey - Application 1738.1

    MSAC application 1738.1 Investigations to support the use of PBS subsidised lecanemab in people with mild cognitive impairment and mild dementia due to Alzheimer’s disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed... More
    Opened 29 May 2026

  • MSAC Consultation Survey - Application 1827

    MSAC application 1827 Testing for hepatitis B virus (HBV) and hepatitis B virus surface antigen (HBsAg) to support the use of PBS subsidised bepirovirsen in people with chronic hepatitis B (CHB). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better... More
    Opened 29 May 2026

  • Framework for consumer engagement in HTA

    We are developing a framework that sets out guiding principles, focus areas and actions to support better consumer engagement in HTA. We'd like to hear your thoughts on the framework and how it could be improved. We will summarise your responses and share the findings so you can see what we heard and how we used the feedback to improve the framework. If you have difficulty responding online, please email htaconsumerengagement@health.gov.au . View the... More
    Closed 26 May 2026

  • Public consultation on items to be considered by the PBAC (July 2026)

    Consultation has opened for the July 2026 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines and vaccines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented by the applicant. Information provided by consumers helps the committee... More
    Closed 20 May 2026

  • MSAC Consultation Survey - Application 1816

    MSAC application 1816 Genetic testing to detect estrogen receptor 1 (ESR1) variants in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer to determine eligibility for treatment with PBS subsidised camizestrant. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). ... More
    Closed 13 March 2026

  • MSAC Consultation Survey - Application 1815

    MSAC application 1815 Computed tomography (CT) of the coronary arteries to determine coronary artery calcium score. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health... More
    Closed 13 March 2026

  • MSAC Consultation Survey - Application 1814

    MSAC application 1814 Bronchoscopic lung volume reduction with endobronchial valves for the treatment of severe emphysema. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian... More
    Closed 13 March 2026

  • MSAC Consultation Survey - Application 1813

    MSAC application 1813 Detection of measurable residual disease in patients with acute myeloid leukaemia. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closed 13 March 2026

  • MSAC Consultation Survey - Application 1817

    MSAC application 1817 Xeomin (incobotulinumtoxinA) injection codes for lower limb spasticity following an acute event. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health... More
    Closed 20 February 2026
110 results. Page 1 of 4